|
|
(One intermediate revision not shown.) |
Line 3: |
Line 3: |
| <StructureSection load='6ncp' size='340' side='right'caption='[[6ncp]], [[Resolution|resolution]] 2.76Å' scene=''> | | <StructureSection load='6ncp' size='340' side='right'caption='[[6ncp]], [[Resolution|resolution]] 2.76Å' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[6ncp]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6NCP OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6NCP FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6ncp]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6NCP OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6NCP FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GLY:GLYCINE'>GLY</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.76Å</td></tr> |
- | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[6nc2|6nc2]], [[6nc3|6nc3]]</td></tr> | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GLY:GLYCINE'>GLY</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6ncp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ncp OCA], [http://pdbe.org/6ncp PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6ncp RCSB], [http://www.ebi.ac.uk/pdbsum/6ncp PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6ncp ProSAT]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6ncp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ncp OCA], [https://pdbe.org/6ncp PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6ncp RCSB], [https://www.ebi.ac.uk/pdbsum/6ncp PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6ncp ProSAT]</span></td></tr> |
| </table> | | </table> |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
Line 17: |
Line 17: |
| </div> | | </div> |
| <div class="pdbe-citations 6ncp" style="background-color:#fffaf0;"></div> | | <div class="pdbe-citations 6ncp" style="background-color:#fffaf0;"></div> |
| + | |
| + | ==See Also== |
| + | *[[Antibody 3D structures|Antibody 3D structures]] |
| == References == | | == References == |
| <references/> | | <references/> |
| __TOC__ | | __TOC__ |
| </StructureSection> | | </StructureSection> |
- | [[Category: Human]] | + | [[Category: Homo sapiens]] |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Wilson, I A]] | + | [[Category: Synthetic construct]] |
- | [[Category: Yuan, M]] | + | [[Category: Wilson IA]] |
- | [[Category: Antibody]] | + | [[Category: Yuan M]] |
- | [[Category: Envelope glycoprotein]]
| + | |
- | [[Category: Fusion peptide]]
| + | |
- | [[Category: Hiv]]
| + | |
- | [[Category: Immune system]]
| + | |
| Structural highlights
Publication Abstract from PubMed
The fusion peptide (FP) of HIV-1 envelope glycoprotein (Env) is essential for mediating viral entry. Detection of broadly neutralizing antibodies (bnAbs) that interact with the FP has revealed it as a site of vulnerability. We delineate X-ray and cryo-electron microscopy (cryo-EM) structures of bnAb ACS202, from an HIV-infected elite neutralizer, with an FP and with a soluble Env trimer (AMC011 SOSIP.v4.2) derived from the same patient. We show that ACS202 CDRH3 forms a "beta strand" interaction with the exposed hydrophobic FP and recognizes a continuous region of gp120, including a conserved N-linked glycan at N88. A cryo-EM structure of another previously identified bnAb VRC34.01 with AMC011 SOSIP.v4.2 shows that it also penetrates through glycans to target the FP. We further demonstrate that the FP can twist and present different conformations for recognition by bnAbs, which enables approach to Env from diverse angles. The variable recognition of FP by bnAbs thus provides insights for vaccine design.
Conformational Plasticity in the HIV-1 Fusion Peptide Facilitates Recognition by Broadly Neutralizing Antibodies.,Yuan M, Cottrell CA, Ozorowski G, van Gils MJ, Kumar S, Wu NC, Sarkar A, Torres JL, de Val N, Copps J, Moore JP, Sanders RW, Ward AB, Wilson IA Cell Host Microbe. 2019 Jun 12;25(6):873-883.e5. doi: 10.1016/j.chom.2019.04.011. PMID:31194940[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Yuan M, Cottrell CA, Ozorowski G, van Gils MJ, Kumar S, Wu NC, Sarkar A, Torres JL, de Val N, Copps J, Moore JP, Sanders RW, Ward AB, Wilson IA. Conformational Plasticity in the HIV-1 Fusion Peptide Facilitates Recognition by Broadly Neutralizing Antibodies. Cell Host Microbe. 2019 Jun 12;25(6):873-883.e5. doi: 10.1016/j.chom.2019.04.011. PMID:31194940 doi:http://dx.doi.org/10.1016/j.chom.2019.04.011
|